Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
ANNX BTA
SE0013748894
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- SEK | -.--% | -3.17% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 13-12-31 |
Chief Executive Officer | 63 | 17-12-31 | |
Director of Finance/CFO | 53 | 23-04-10 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 23-01-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 20-12-31 |
Mårten Österlund
BRD | Director/Board Member | 67 | 20-12-31 |
Chief Executive Officer | 63 | 17-12-31 | |
Director/Board Member | 48 | 16-12-31 | |
Director/Board Member | 65 | 15-12-31 | |
Director/Board Member | 66 | 16-12-31 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 256,124,467 ( 48.62 %) | 0 | 48.62 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ANNX Stock
- ANNX BTA Stock
- Company Annexin Pharmaceuticals AB (publ)